How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Colorectal Cancer

Select Clinical Trial

Colorectal Cancer

NSABP C-13 (ARGO): A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer

  • Men and women, ages 18 and older, diagnosed with Stage IIIB or IIIC colon cancer. For more information, please contact the study coordinator at 910-715-2200.


NSABP MPR-1/ Colorectal

  • Patient Registry and Biospecimen Profiling Repository - this is a study to collect and analyze tissue specimens from metastatic colorectal cancer (mCRC) patients for the primary purpose of maintaining a patient registry for future clinical trials based on the molecular profile of the tumors.


  • Patient population: 18 Years and older; diagnosis of metastatic colorectal adenocarcinoma
Clara McLean House
Make a Donation
News & Events